$3.845
+0.097 (+2.53%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
VNDA-Prognose durch Analyse ähnlicher Charts
Alphio's VNDA stock price prediction model matches the current Vanda Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.55 (-1.44%). The 1-week path is $3.64 (+0.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Vanda Pharmaceuticals Inc-Aktien kaufen?
Vanda Pharmaceuticals Inc is currently priced at $3.88, which is significantly below its 52-week high of $9.94, indicating potential upside. However, the stock has a low RSI of 35.207, suggesting it is oversold, but the forward P/E ratio is high at 103.09, indicating that the stock may be overvalued based on future earnings expectations. The recent insider selling has increased by 972.59%, which raises concerns about the company's outlook. Therefore, while there is potential for recovery, the risks associated with high valuation and insider selling suggest a hold position for now.
VNDA schloss am Wednesday bei $3.85, nachdem der Kurs +2.53% gestiegen ist
Vanda Pharmaceuticals Inc (VNDA) last closed at $3.605, losing -6.24%. These facts feed the 1-day and 1-week VNDA price prediction above.
Analystenkonsens
Vanda Pharmaceuticals Inc (VNDA): 5 Kaufen, 0 Halten, 1 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Vanda Pharmaceuticals Inc (VNDA) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf VNDA am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für VNDA
Historically the probability of a positive November return for VNDA is 62.79%. December offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für VNDA
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $4.91 | $6.02 | $7.09 | +67.09% |
| Dec 2026 | $4.78 | $5.69 | $6.72 | +57.85% |
Für 2026 wird für Vanda Pharmaceuticals Inc (VNDA) eine Spanne von $4.78 bis $7.09 projiziert.
Monatsprognose 2026 für Vanda Pharmaceuticals Inc
Im Nov 2026 wird für Vanda Pharmaceuticals Inc ein Durchschnitt von $6.02 erwartet, mit einem Tief von $4.91 und einem Hoch von $7.09.
Im Dec 2026 wird für Vanda Pharmaceuticals Inc ein Durchschnitt von $5.69 erwartet, mit einem Tief von $4.78 und einem Hoch von $6.72.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.